Literature DB >> 7689581

Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice.

D S Skundric1, C Kim, H Y Tse, C S Raine.   

Abstract

Chronic relapsing experimental allergic encephalomyelitis (EAE) was induced in Thy-1.1 congenic SJL/J mice by the adoptive transfer of myelin basic protein (MBP)-responsive lymph node cells from Thy-1.2 SJL/J mice. The Thy-1 congenic mouse strain was constructed on the SJL (Thy-1.2) background by the initial cross with the AKR (Thy-1.1) strain and does not reject Thy-1.2+ T cells. Quantitative immunocytochemical analysis of the central nervous system (CNS) of Thy-1.1 recipients showed preferential trafficking of Thy-1.2+ T cells to the meninges and white matter, beginning prior to onset of clinical signs. At 7 days post-transfer (dpt), Thy-1.2+ donor cells constituted 2.5% of the infiltrating cells and reached peak values (ca. 10%) during the first attack. At later stages (up to ten relapses), Thy-1.2+ T cells constituted 2-5% of the infiltrate. In control mice injected with irrelevant antigen-stimulated Thy-1.2+ T cells, only the occasional Thy-1.2+ T cell could be demonstrated up to 14 dpt. This is the first study showing unequivocally the presence of MBP-stimulated, adoptively transferred T cells within the CNS of recipients throughout the course of EAE, particularly during later relapsing stages. These results indicate that the persistent presence of antigen-specific T cells may be required for the recruitment of non-CNS antigen-responsive immune cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689581     DOI: 10.1016/0165-5728(93)90240-y

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.

Authors:  Joshua S Stoolman; Patrick C Duncker; Amanda K Huber; Benjamin M Segal
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

4.  Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis.

Authors:  Harley Y Tse; Jinzhu Li; Xiaoqing Zhao; Fei Chen; Peggy P Ho; Michael K Shaw
Journal:  Curr Trends Immunol       Date:  2012

5.  Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis.

Authors:  Nathanael D Reynolds; Nicholas W Lukacs; Nancy Long; William J Karpus
Journal:  J Immunol       Date:  2011-07-25       Impact factor: 5.422

6.  T cells that trigger acute experimental autoimmune encephalomyelitis also mediate subsequent disease relapses and predominantly produce IL-17.

Authors:  Jinzhu Li; Xiaoqing Zhao; Hui-Wen Hao; Michael K Shaw; Harley Y Tse
Journal:  J Neuroimmunol       Date:  2010-09-09       Impact factor: 3.478

7.  Experimental autoimmune encephalomyelitis in the mouse.

Authors:  Stephen D Miller; William J Karpus
Journal:  Curr Protoc Immunol       Date:  2007-05

8.  Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Rachael L Terry; Igal Ifergan; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2016

9.  Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.

Authors:  Andre Michael Mueller; Bo Hyung Yoon; Saud Ahmed Sadiq
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

10.  IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.

Authors:  Eunyoung Lee; Sarah Chanamara; David Pleasure; Athena M Soulika
Journal:  J Neuroinflammation       Date:  2012-01-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.